WHAT THE STUDY ACTUALLY SAYS

Drinking more water did not slow kidney decline in the one trial that tested it

Observational studies link higher water intake to healthier kidneys. When a randomised trial coached people with kidney disease to drink more, their filtration fell at the same rate as the control group.

Mean eGFR decline over 12 months, CKD WIT trialDrink-more-water group: 2.2mL/min/1.73m²; Usual-intake group: 1.9mL/min/1.73m²0mL/min/1.73m²1.5mL/min/1.73m²3mL/min/1.73m²Drink-more-water group2.2mL/min/1.73m²Usual-intake group1.9mL/min/1.73m²
Mean eGFR decline over 12 months, CKD WIT trial
GroupValue (mL/min/1.73m²)
Drink-more-water group2.2
Usual-intake group1.9
Mean eGFR decline over 12 months, CKD WIT trial Adults with stage 3 chronic kidney disease, coached to drink more water or to maintain usual intake. Values are the mean fall in filtration rate; the adjusted between-group difference was not significant (P = .74). Source: JAMA

The idea that drinking more water protects the kidneys is intuitive and widely repeated, but the one randomised trial designed to test it found no benefit: among adults with chronic kidney disease, coaching people to drink more water did not slow the decline in kidney function over a year compared with coaching them to keep their usual intake [s1]. The observational link between higher water intake and healthier kidneys is real in the data — it just did not hold up when put to a controlled test [s1] [s2].

Where the belief comes from

The belief has an evidence base, and it is worth stating fairly. A cross-sectional analysis of US National Health and Nutrition Examination Survey data examined the relationship between total water intake, chronic kidney disease and cardiovascular disease in the general population [s2]. Among 3,427 adults, 13% had chronic kidney disease [s2]. Those with the lowest total water intake, under 2.0 litres a day, had higher odds of chronic kidney disease than those with the highest intake, over 4.3 litres a day — an adjusted odds ratio of 2.52, though with a wide confidence interval that crossed 1 (95% CI, 0.91 to 6.96) [s2]. This is the kind of finding that launches a health rule: a plausible mechanism, animal support, and a population association pointing the expected way.

But an association like this cannot separate cause from consequence or from confounding. People who drink less water may differ in many ways from people who drink more, and impaired kidneys may change thirst and fluid handling rather than the other way round. That is what a randomised trial is for.

What the trial actually did

The CKD WIT trial — Chronic Kidney Disease Water Intake Trial — ran at nine centres in Ontario, Canada, from 2013 to 2017 [s1]. It enrolled 631 patients with stage 3 chronic kidney disease, randomising 316 to a hydration group coached to drink more water and 315 to a control group coached to maintain their usual intake [s1]. The coaching worked as intended: the hydration group's 24-hour urine volume rose by 0.6 litres a day more than the control group's, a clear, statistically significant separation confirming the two groups really did drink differently [s1].

The kidneys did not care. The primary outcome was the change in estimated glomerular filtration rate — eGFR, the standard measure of filtering capacity — over 12 months. It fell by 2.2 mL/min/1.73m² in the hydration group and by 1.9 in the control group, an adjusted between-group difference of just −0.3 (95% CI, −1.8 to 1.2; P = .74) [s1]. That is a null result: the extra water made no meaningful difference to how fast kidney function declined [s1]. A marker of the body's water-conserving hormone, plasma copeptin, did fall more in the hydration group, confirming the intervention reached the physiology it was aimed at — but the filtration outcome that matters did not move [s1].

The honest caveat the authors themselves raise

The trial's own conclusion carries a limit worth quoting in spirit: the authors note the study may have been underpowered to detect a clinically important difference [s1]. A single one-year trial in stage 3 disease cannot rule out a small benefit, or a benefit over a longer horizon, or a benefit in a different group — such as people prone to kidney stones, for whom higher fluid intake has separate and better evidence, or people who are genuinely dehydrated. What CKD WIT does establish is narrower and still useful: coaching people with established kidney disease to drink substantially more water, enough to raise urine output by more than half a litre a day, did not slow their decline over a year [s1].

What this leaves a reader with

Higher water intake tracks with better kidney health in observational data, but the trial built to test whether drinking more causes better kidney function found no effect on the decline of filtration over a year [s1] [s2]. That does not argue for drinking too little — ordinary thirst-guided intake and the separate, stronger case for fluids in kidney-stone prevention both stand. It argues against the specific claim that pushing extra water protects failing kidneys, which the one randomised test did not support. Anyone with chronic kidney disease has fluid targets that are genuinely individual, and a matter for their clinician rather than a general rule.

This article is informational and is not medical advice.

Sources

Sources

  1. Effect of Coaching to Increase Water Intake on Kidney Function Decline in Adults With Chronic Kidney Disease: The CKD WIT Randomized Clinical TrialJAMA , May 8, 2018
  2. Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES dataAmerican Journal of Nephrology , April 17, 2013

More on

Related coverage